Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOLIFE SOLUTIONS INCBLFS · Entity 4614 | Director | November 24, 2020 | December 01, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOLIFE SOLUTIONS INC
Report date November 24, 2020 · Filed December 01, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Taurus4757 GmbH | 47,774 |
Reported balance
After 2020-11-24 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2020-11-24 · Sale · Disposed 1,600,000 · Balance 47,774 F1: The reported securities were sold to Casdin Partners Master Fund, L.P. in a private transaction (the "Transaction"). As of November 24, 2020, all material conditions precedent to closing the Transaction have been satisfied. F2: The shares of common stock, par value $0.001 per share, are held directly by Taurus457 GmbH an entity wholly owned by Thomas Girschweiler, a director of Biolife Solutions, Inc. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported securities were sold to Casdin Partners Master Fund, L.P. in a private transaction (the "Transaction"). As of November 24, 2020, all material conditions precedent to closing the Transaction have been satisfied.
F2: The shares of common stock, par value $0.001 per share, are held directly by Taurus457 GmbH an entity wholly owned by Thomas Girschweiler, a director of Biolife Solutions, Inc.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 24, 2020 Filed Dec 1, 2020 00:49 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,600,000 | $22.50 | $36,000,000.00 |
DisclosureSEC source: 0001437749-20-024588 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 47,774 F1 · kind: The reported securities were sold to Casdin Partners Master Fund, L.P. in a private transaction (the "Transaction"). As of November 24, 2020, all material conditions precedent to closing the Transaction have been satisfied. F2 · ownership.nature: The shares of common stock, par value $0.001 per share, are held directly by Taurus457 GmbH an entity wholly owned by Thomas Girschweiler, a director of Biolife Solutions, Inc. Read SEC document |
| October 05, 2020 Filed Oct 8, 2020 00:31 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-20-020872 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 1,647,774 F1 · price: The restricted stock was granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests on the twelve-month anniversary of the grant date. F2 · ownership.nature: The shares of common stock, par value $0.001 per share, are held directly by Taurus457 GmbH an entity wholly owned by Thomas Girschweiler, a director of Biolife Solutions, Inc. Read SEC document |
| July 02, 2020 Filed Jul 2, 2020 22:32 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 305,583 | $14.50 | $4,430,953.50 |
DisclosureSEC source: 0001437749-20-014578 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 1,642,774 F1 · ownership.nature: The shares of common stock, par value $0.001 per share, are held directly by Taurus457 GmbH an entity wholly owned by Thomas Girschweiler, a director of Biolife Solutions, Inc. Read SEC document |
| May 22, 2020 Filed Jun 4, 2020 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 476,191 | $10.50 | $5,000,005.50 |
DisclosureSEC source: 0001437749-20-012378 · rdgdoc.xml · nonDerivative · entry 5 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 1,948,357 Read SEC document |
| May 13, 2020 Filed Jun 4, 2020 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | OtherWarrants (Right to Buy) · Derivative | 1,544,194 | Not disclosed Strike: $4.75 | Not disclosed |
DisclosureSEC source: 0001437749-20-012378 · rdgdoc.xml · derivative · entry 7 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 0 Underlying: Common Stock · 1,544,194 shares Expires 2021-03-25 F2 · kind: On May 13, 2020, the reporting person exercised an in-the-money warrant to purchase 1,544,194 shares of Common Stock of the Company for $4.75 per share pursuant to Rule 16b-6 under the Securities Exchange Act of 1934, as amended. The reporting person exercised the warrant on a cashless basis pursuant to the terms of the warrant, resulting in the Company's withholding of 492,277 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,051,197 shares. F3 · price: The warrants were issued to Taurus in March 2014 in connection with conversion of outstanding promissory notes and interest accrued thereon for units consisting of common stock and warrants. Read SEC document |
| May 13, 2020 Filed Jun 4, 2020 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 492,277 | $14.90 | $7,334,927.30 |
DisclosureSEC source: 0001437749-20-012378 · rdgdoc.xml · nonDerivative · entry 4 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 2,424,548 F2 · kind: On May 13, 2020, the reporting person exercised an in-the-money warrant to purchase 1,544,194 shares of Common Stock of the Company for $4.75 per share pursuant to Rule 16b-6 under the Securities Exchange Act of 1934, as amended. The reporting person exercised the warrant on a cashless basis pursuant to the terms of the warrant, resulting in the Company's withholding of 492,277 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,051,197 shares. Read SEC document |
| May 13, 2020 Filed Jun 4, 2020 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | OtherCommon Stock | 1,544,194 | $4.75 | $7,334,921.50 |
DisclosureSEC source: 0001437749-20-012378 · rdgdoc.xml · nonDerivative · entry 3 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 2,916,825 F2 · kind: On May 13, 2020, the reporting person exercised an in-the-money warrant to purchase 1,544,194 shares of Common Stock of the Company for $4.75 per share pursuant to Rule 16b-6 under the Securities Exchange Act of 1934, as amended. The reporting person exercised the warrant on a cashless basis pursuant to the terms of the warrant, resulting in the Company's withholding of 492,277 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,051,197 shares. Read SEC document |
| January 30, 2020 Filed Feb 4, 2020 01:39 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,714 | $0.00 Strike: $1.40 | $0.00 |
DisclosureSEC source: 0001437749-20-001603 · rdgdoc.xml · derivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires 2020-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 30, 2020 Filed Feb 4, 2020 01:39 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 10,714 | $1.40 | $15,010.31 |
DisclosureSEC source: 0001437749-20-001603 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,524,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares of common stock were issued to Taurus4757 GmbH, a wholly owned entity of the reporting person, upon exercise of the warrants held by the reporting person. Read SEC document |
| October 04, 2019 Filed Jun 4, 2020 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 162,760 | $15.36 | $2,499,993.60 |
DisclosureSEC source: 0001437749-20-012378 · rdgdoc.xml · nonDerivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 1,372,631 Read SEC document |
| January 17, 2019 Filed Jun 4, 2020 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionStock Option (Right to Buy) · Derivative | 10,714 | $0.00 Strike: $1.26 | $0.00 |
DisclosureSEC source: 0001437749-20-012378 · rdgdoc.xml · derivative · entry 6 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,714 shares Expires 2019-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2019 Filed Jun 4, 2020 00:00 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 10,714 | $1.26 | $13,510.35 |
DisclosureSEC source: 0001437749-20-012378 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 1,535,391 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares of common stock, par value $0.001 per share (the "Common Stock") were issued to Taurus457 GmbH ("Taurus"), an entity wholly owned by Thomas Girschweiler (together with Taurus, the "reporting person") a director and 10% shareholder of Biolife Solutions, Inc. (the "Company"), upon exercise of the warrants held by the reporting person. Read SEC document |
| July 09, 2018 Filed Jul 9, 2018 21:56 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 252,571 | $11.37 | $2,871,732.27 |
DisclosureSEC source: 0001437749-18-013144 · rdgdoc.xml · nonDerivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,513,963 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| July 09, 2018 Filed Jul 9, 2018 21:56 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 33,143 | $11.37 | $376,835.91 |
DisclosureSEC source: 0001437749-18-013144 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,766,534 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 23:26 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 25,000 | $5.26 | $131,500.00 |
DisclosureSEC source: 0001437749-18-006639 · rdgdoc.xml · nonDerivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,799,677 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| April 09, 2018 Filed Apr 10, 2018 23:26 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | SaleCommon Stock | 1,000,000 | $5.26 | $5,260,000.00 |
DisclosureSEC source: 0001437749-18-006639 · rdgdoc.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 1,824,677 F1 · shares: The reporting person sold the shares in privately negotiated transactions. Read SEC document |
| January 03, 2018 Filed Jan 4, 2018 02:29 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 834 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-000667 · tv482648_4.xml · nonDerivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 2,824,677 F2 · price: The shares of common stock were issued to Taurus pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| January 01, 2018 Filed Jan 4, 2018 02:29 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 10,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-18-000667 · tv482648_4.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 2,823,843 F1 · shares: The restricted stock was granted to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. F1 · price: The restricted stock was granted to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. Read SEC document |
| October 03, 2017 Filed Oct 3, 2017 20:04 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 887 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-051153 · v476390_4.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 2,813,843 F1 · price: The shares of common stock were issued to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| July 06, 2017 Filed Jul 7, 2017 20:03 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 2,092 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-036094 · v470493_4.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 2,812,956 F1 · price: The shares of common stock were issued to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter at a price per share based upon the closing stock price of the issuer's common stock on the last day of the quarter. Read SEC document |
| May 26, 2017 Filed May 26, 2017 20:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | OtherWarrants · Derivative | 71,429 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001144204-17-029845 · v467956.xml · derivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 71,429 shares Expires 2017-05-29 Read SEC document |
| May 26, 2017 Filed May 26, 2017 20:05 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | OtherCommon Stock | 71,429 | $1.12 | $80,000.48 |
DisclosureSEC source: 0001144204-17-029845 · v467956.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 2,810,864 F1 · ownership.nature: The shares of common stock were issued to Taurus4757 GmbH, a wholly owned entity of the reporting person, upon exercise of the warrants held by the reporting person. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 01:54 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 2,381 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-019305 · v463691_4.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 2,739,435 F1 · price: The shares of common stock were issued to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter. Read SEC document |
| February 06, 2017 Filed Feb 10, 2017 00:39 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionStock Option (Right to Buy) · Derivative | 17,857 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0001144204-17-007170 · v458955_4.xml · derivative · entry 2 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,857 shares Expires 2017-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2017 Filed Feb 10, 2017 00:39 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | Exercise / conversionCommon Stock | 17,857 | $1.12 | $19,999.84 |
DisclosureSEC source: 0001144204-17-007170 · v458955_4.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus Disclosed balance after: 2,737,054 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares of common stock were issued to Taurus4757 GmbH, a wholly owned entity of the reporting person, upon exercise of the options held by the reporting person. Read SEC document |
| January 13, 2017 Filed Jan 19, 2017 00:34 UTC | BIOLIFE SOLUTIONS INC BLFS · Entity 4614 | GrantCommon Stock | 3,106 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001144204-17-002791 · v456505_4.xml · nonDerivative · entry 1 GIRSCHWEILER THOMAS · CIK 0001273547 · Director · 10% owner Taurus4757 GmbH · CIK 0001603397 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Taurus4757 GmbH Disclosed balance after: 2,719,197 F1 · price: The shares of common stock were issued to Taurus4757 GmbH ("Taurus"), a wholly owned entity of the reporting person, pursuant to the BioLife Solutions 2013 Performance Incentive Plan in lieu of the reporting person receiving $5,000 of director fees for the quarter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.